COMMUNIQUÉS West-GlobeNewswire

Major Shareholder Announcement
19/06/2019
Company Announcement Major shareholder announcement for Genmab A/S Copenhagen, Denmark; June 19, 2019 – Genmab A/S (Nasdaq Copenhagen: GEN) announces under reference to Section 30 of the Danish Capital Markets Act that [...]
Network Health Expands Relationship with Inovalon
19/06/2019
Leading Health Plan Extends Engagement and Adds CDEaaS™ and NLPaaS™ to Enable Fully Automated Capture and Analysis of Structured and Unstructured Clinical Data at Large Scale BOWIE, Md., June 19, 2019 (GLOBE NEWSWIRE [...]
Akari Therapeutics’ Nomacopan Demonstrates Positive Early Safety and Efficacy in Phase I/II Clinical Study in Moderate-to-Severe Atopic Keraconjunctivitis (AKC)
19/06/2019
Part A of a safety and efficacy study successfully completed with nomacopan eye drops which were well tolerated with no serious adverse events. Improvement in mean composite clinical efficacy score of 35% by Day 14 and [...]
Melinta Therapeutics Announces U.S. FDA Acceptance of Supplemental New Drug Application for BAXDELA® (delafloxacin) for the Treatment of Community-Acquired Bacterial Pneumonia
19/06/2019
~ Application Seeks to Expand Label to Include an Indication and Phase III Data for the Treatment of Adult Patients with Community-Acquired Bacterial Pneumonia (CABP) ~ ~ PDUFA Date Set for October 24, 2019 ~ MORRISTOWN [...]
Scholar Rock to Present at the 2019 BMO Prescriptions for Success Healthcare Conference
19/06/2019
CAMBRIDGE, Mass., June 19, 2019 (GLOBE NEWSWIRE) -- Scholar Rock Holding Corporation (NASDAQ: SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth [...]
ProMIS Neurosciences Appoints Renowned Parkinson’s Disease Expert Dr. C. Warren Olanow to Scientific Advisory Board
19/06/2019
Internationally recognized leader in neurodegenerative diseases to advise on programs selectively targeting the toxic oligomer TORONTO and CAMBRIDGE, Mass., June 19, 2019 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. ( [...]
CURE Pharmaceutical [OTCQB:CURR] and Canopy Growth to Produce CBD Oral Thin Films
19/06/2019
OXNARD, Calif. , June 19, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced it is collaborating with Canopy Growth Corporation (TSX: WEED) ( [...]
Arch Biopartners Announces Start of Phase I Human Trial for Metablok
19/06/2019
TORONTO, June 19, 2019 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today it has initiated the Phase I human trial for Metablok (“LSALT peptide”), [...]
Myriad Genetics Receives Second Insurance Reimbursement Decision for its BRACAnalysis® Diagnostic System in Japan
19/06/2019
BRACAnalysis Is Now Indicated as a Companion Diagnostic for Lynparza® (olaparib) in Women with Ovarian Cancer SALT LAKE CITY, June 19, 2019 (GLOBE NEWSWIRE) -- Myriad Genetic Laboratories, Inc., a wholly-owned [...]
PLx Pharma on Track for VAZALORE Regulatory Pathway
19/06/2019
HOUSTON, June 19, 2019 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company initially focused on developing its clinically validated and patent- [...]
Nabriva Therapeutics Submits Type A Meeting Request to FDA for Intravenous CONTEPO™ (fosfomycin) for injection
19/06/2019
DUBLIN, Ireland, June 19, 2019 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a clinical-stage biopharmaceutical company engaged in the development of innovative anti-infective agents to treat serious [...]
Sorrento Therapeutics Updates Positive Results of Phase 1b Resiniferatoxin (RTX) in Knee Osteoarthritis Pain Trial
19/06/2019
Forty five patients were treated with escalating doses of RTX in the Phase 1b trial to date. Thirty seven patients received RTX and eight patients received saline (pooled as placebo group). Most adverse events [...]
Abeona Therapeutics reçoit la désignation « Fast Track » de la FDA pour la thérapie génique ABO‑202 AAV9 dans la maladie CLN1
19/06/2019
NEW YORK et CLEVELAND, 19 juin 2019 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq : ABEO), chef de file entièrement intégré dans la thérapie génique et cellulaire, a annoncé aujourd'hui que la Food and Drug [...]
Fennec Announces Results of Annual Meeting
19/06/2019
RESEARCH TRIANGLE PARK, N.C., June 19, 2019 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (the “Company”) (NASDAQ:FENC) (TSX:FRX) today announced that the nominees listed in the management proxy circular dated May 14 [...]
MediPharm Labs and Ace Valley Enter Vape Oil White Label Deal
19/06/2019
TORONTO, June 19, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) , a leader in specialized, research-driven cannabis extraction and cannabinoid [...]
Amphastar Pharmaceuticals, Inc. Announces Settlement in Litigation with Momenta and Sandoz
19/06/2019
RANCHO CUCAMONGA, Calif., June 19, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc., (NASDAQ: AMPH) today announced that it has entered into a settlement agreement (the “Settlement Agreement”) with Momenta [...]
RAFARMA Adds Blockchain Tech to Cannabis Distribution
19/06/2019
Ljubljana, Slovenia, June 19, 2019 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals Inc (OTC: RAFA), a Wyoming Corporation, is pleased to announce an agreement with Aetsoft LLC. Aetsoft is one of the leading developers of [...]
C-RAD announces resignation of board member
19/06/2019
C-RAD announces today that Peter Eidensjö has announced that he resigns from the Company's board of directors, effective June 19, 2019. "On behalf of our board of directors, I thank Peter for his valuable service and [...]
1,767 Orion Corporation A shares converted into B shares
19/06/2019
ORION CORPORATION STOCK EXCHANGE RELEASE 19 JUNE 2019 at 9.30 EEST 1,767 Orion Corporation A shares converted into B shares In accordance with Section 3 of the Articles of Association of Orion Corporation, 1,767 A [...]

Pages